These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 8561197)

  • 21. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
    Kasper S; Tauscher J; Küfferle B; Barnas C; Hesselmann B; Asenbaum S; Podreka I; Brücke T
    Psychopharmacology (Berl); 1998 Apr; 136(4):367-73. PubMed ID: 9600582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S; Schlösser R; Hiemke C; Nickel O; Bockisch A; Hahn K
    Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
    Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW
    Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Meisenzahl EM; Schmitt G; Gründer G; Dresel S; Frodl T; la Fougère C; Scheuerecker J; Schwarz M; Boerner R; Stauss J; Hahn K; Möller HJ
    Pharmacopsychiatry; 2008 Sep; 41(5):169-75. PubMed ID: 18763218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between striatal dopamine D2/D3 receptor binding and cardiovascular activity in healthy subjects.
    Yeh TL; Yang YK; Chiu NT; Yao WJ; Yeh SJ; Wu JS; Chuang JI; Chang SH
    Am J Hypertens; 2006 Sep; 19(9):964-9. PubMed ID: 16942941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA
    J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
    Jauss M; Krack P; Franz M; Klett R; Bauer R; Gallhofer B; Dorndorf W
    Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine.
    Raedler TJ; Knable MB; Lafargue T; Urbina RA; Egan MF; Pickar D; Weinberger DR
    Psychiatry Res; 1999 Apr; 90(2):81-90. PubMed ID: 10482380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of dopamine receptor occupancy by [123I]IBZM-SPECT in schizophrenic patients treated with quetiapine.
    Pávics L; Szekeres G; Ambrus E; Kéri S; Kovács Z; Argyelán M; Kanyó B; Csernay L; Janka Z
    Nucl Med Rev Cent East Eur; 2004; 7(2):129-33. PubMed ID: 15968599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine.
    Tauscher J; Küfferle B; Asenbaum S; Brücke T; Kasper S
    Psychopharmacology (Berl); 1997 Sep; 133(1):102-5. PubMed ID: 9335088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S; Mager T; Rossmüller B; Meisenzahl E; Hahn K; Möller HJ; Tatsch K
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophrenia.
    Bressan RA; Costa DC; Jones HM; Ell PJ; Pilowsky LS
    Schizophr Res; 2002 Jul; 56(1-2):31-6. PubMed ID: 12084417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [D2-dopamine receptor upregulation and treatment response under neuroleptic therapy].
    Schröder J; Bubeck B; Sauer H
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S42-5. PubMed ID: 10907613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT.
    Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
    Psychiatry Res; 2009 Sep; 173(3):183-9. PubMed ID: 19683898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
    Küfferle B; Tauscher J; Asenbaum S; Vesely C; Podreka I; Brücke T; Kasper S
    Psychopharmacology (Berl); 1997 Oct; 133(4):323-8. PubMed ID: 9372530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.